Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cells
Mariet C.W. Feltkamp(Leiden University Medical Center), W. Martin Kast(University of Southern California), Cornelis J.M. Melief(ISA Pharmaceuticals (Netherlands)), Michel Vierboom(Biomedical Primate Research Centre), René Minnaar(Amsterdam University Medical Centers), B. M. de Jongh(University Medical Center Utrecht), Jan ter Schegget(Department of Virology), Henk L. Smits(Amsterdam UMC Location University of Amsterdam), Jan W. Drijfhout(Leiden University)
Cited by 840
Related Papers
Therapeutic cancer vaccines
|Journal of Clinical Investigation|2015|1.1k
Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity
|Nature Medicine|1995|1.1k
The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes.
|The Journal of Immunology|1994|851
Decontamination of the Digestive Tract and Oropharynx in ICU Patients
|New England Journal of Medicine|2008|823
Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells
|Nature Medicine|2002|549